Osteoblastoma is a benign bone-forming tumor histologically identical to osteoid osteoma but >2cm in size, more expansile, and showing less reactive sclerosis. The posterior elements of the vertebra (pedicle, lamina, spinous process) are the predilection site. It also occurs in the diaphysis and metaphysis of long bones. Unlike osteoid osteoma, its pain does not fully respond to aspirin/NSAIDs.
Age Range
10-35
Peak Age
20
Gender
Male predominant
Prevalence
Rare
Osteoblastoma is a bone-forming tumor characterized by benign neoplastic proliferation of osteoblasts. Tumor cells produce irregular osteoid and immature bone trabeculae; this osteoid matrix is histologically identical to that in osteoid osteoma but the lesion size is >2cm. The larger size and expansile growth pattern of osteoblastoma results in less reactive sclerosis in surrounding bone compared to osteoid osteoma — this forms the basis of radiological distinction. The predilection for vertebral posterior elements is attributed to the endochondral ossification dynamics and rich vascularity of this region. On CT, mineralized osteoid matrix within the expansile lesion shows variable density; on MRI, the T2 signal character of osteoid matrix depends on the degree of mineralization — T2 hyperintense with low mineralization (soft osteoid), T2 hypointense with high mineralization (ossified matrix). Peritumoral edema is less prominent than in vertebral chordoma but is present.
Expansile lytic-sclerotic lesion >2cm in vertebral posterior element (pedicle, lamina, spinous process) with variable mineralized osteoid matrix and minimal surrounding reactive sclerosis. This finding is highly suggestive of osteoblastoma in the 10-30 age group. The combination of posterior element + >2cm + less sclerosis distinguishes from osteoid osteoma.
On CT, an expansile lesion >2cm is seen in the vertebral posterior element or long bone diaphysis/metaphysis. Variable density osteoid matrix mineralization (amorphous, fragmented, or dense calcification) is present within the lesion. No sharply defined nidus as in osteoid osteoma — the matrix is scattered and heterogeneous. Surrounding reactive sclerosis is significantly less than in osteoid osteoma. A thin cortical shell borders the lesion — bone expansion is present.
Report Sentence
On CT, an expansile lesion >2cm is identified in the L3 vertebral pedicle-lamina with heterogeneous mineralized osteoid matrix and thin cortical shell within the lesion; surrounding reactive sclerosis is minimal.
On T2-weighted series, osteoblastoma demonstrates heterogeneous signal. Low-mineralized osteoid areas show T2 hyperintense signal, while highly mineralized areas show T2 hypointense signal. Peritumoral bone marrow edema appears as a T2 hyperintense rim — this edema can be confused with aggressive tumor but is generally moderate relative to lesion size. In spinal locations, spinal canal narrowing and neural element compression should be evaluated.
Report Sentence
On T2-weighted series, the lesion in the vertebral posterior element demonstrates heterogeneous signal with moderate surrounding bone marrow edema.
On T1-weighted series, osteoblastoma demonstrates low to intermediate signal. Tumor tissue replacing normal bone marrow fat signal is hypointense on T1. Mineralized matrix areas also show low T1 signal. Peritumoral edema is slightly hypointense on T1, separating from surrounding marrow.
Report Sentence
On T1-weighted series, low to intermediate signal with loss of normal bone marrow fat signal is demonstrated in the vertebral posterior element lesion.
On post-contrast T1 series, intense enhancement is observed in the solid vascular component of osteoblastoma. Mineralized matrix areas do not enhance. Fat-suppressed post-contrast series best evaluate the true size and distribution of the tumor's vascular component. Peritumoral edema may show mild enhancement. In spinal lesions, epidural enhancement indicates spinal canal invasion.
Report Sentence
On fat-suppressed post-contrast series, intense enhancement is noted in the solid component of the lesion, while mineralized matrix areas do not enhance.
On STIR sequence, fat suppression makes peritumoral edema and the solid component of the tumor conspicuous. In vertebral lesions, extension to adjacent vertebral body and paraspinal soft tissue is best assessed with STIR. Tumor extension into the spinal canal and epidural component appear as hyperintense signal on STIR.
Report Sentence
On STIR sequence, bright signal in the solid component of the lesion and surrounding bone marrow edema are demonstrated, with evaluation of epidural extension.
On DWI, mild-to-moderate restricted diffusion may be observed in the solid vascular component of osteoblastoma (ADC: 1.0-1.5 × 10⁻³ mm²/s). It shows higher ADC values than aggressive bone tumors (osteosarcoma, Ewing). Susceptibility artifact in mineralized matrix areas may complicate DWI assessment.
Report Sentence
On DWI, mild restricted diffusion is noted in the solid component of the lesion (ADC: ~1.2 × 10⁻³ mm²/s), with benign-level diffusion values inconsistent with aggressive bone tumors.
Criteria
Well-defined, expansile, benign histology (atypical osteoblasts and osteoid production), low recurrence rate (10-20%)
Distinct Features
Well-defined expansile lesion on CT, thin cortical shell intact. Heterogeneous T2 signal on MRI, intense enhancement. Treated with intralesional curettage or en-bloc excision. Recurrence may occur after incomplete excision.
Criteria
Locally aggressive growth, cortical perforation, soft tissue extension, 'epithelioid' osteoblasts in histology, high recurrence rate (40-50%)
Distinct Features
Cortical perforation and soft tissue mass on CT — more aggressive appearance than conventional type. More prominent peritumoral edema and enhancement on MRI. Difficult to distinguish from osteosarcoma — biopsy mandatory. Wide surgical excision required, recurrence common. Malignant transformation rare but reported.
Criteria
Osteoblastoma + secondary aneurysmal bone cyst (ABC) component, in vertebral posterior elements, young age group
Distinct Features
On MRI, fluid-fluid levels (in ABC component) + solid enhancing component (osteoblastoma) coexist. CT shows expansile lesion + mineralized matrix + cystic areas. Presence of ABC component increases bleeding risk during surgery. Preoperative embolization recommended.
Distinguishing Feature
Osteoid osteoma shows <2cm nidus + prominent surrounding reactive sclerosis. Osteoblastoma is characterized by >2cm, more expansile growth, and less reactive sclerosis. Pain in osteoid osteoma fully responds to aspirin/NSAIDs; response is partial in osteoblastoma. On CT, osteoid osteoma nidus is sharply defined while osteoblastoma matrix is more scattered.
Distinguishing Feature
Osteosarcoma shows more aggressive bone destruction, more prominent soft tissue mass, sunburst periosteal reaction, and Codman triangle. Osteoblastoma is more expansile/well-defined while osteosarcoma shows permeative destruction. Osteosarcoma shows lower ADC values on DWI. Biopsy is mandatory — aggressive osteoblastoma can histologically mimic osteosarcoma.
Distinguishing Feature
Primary aneurysmal bone cyst (ABC) consists entirely of cystic components (fluid-fluid levels) with minimal solid enhancing component. Osteoblastoma has dominant solid tumoral component and contains mineralized matrix. Secondary ABC can develop within osteoblastoma — combined solid + cystic lesion suggests secondary ABC.
Distinguishing Feature
Giant cell tumor is epiphyseal/subchondral in location and contains no mineralized matrix (purely lytic). Osteoblastoma is located in posterior elements and metaphysis and contains mineralized osteoid matrix. Giant cell tumor typically occurs at age 20-40 while osteoblastoma is in the 10-30 age group.
Urgency
semi-urgentManagement
Konvansiyonel osteoblastom: intralezyonel küretaj + kemik grefti veya en-bloc eksizyon. Agresif osteoblastom: geniş cerrahi eksizyon (marginal/geniş sınır). Spinal lezyonlarda preoperatif embolizasyon kanama riskini azaltır. Radyofrekans ablasyon — osteoid osteomanın aksine osteoblastomda boyut nedeniyle genellikle uygun değildir.Biopsy
NeededFollow-up
Cerrahi sonrası 6-12 aylık BT/MRG ile rekürrens takibi. Agresif osteoblastomda daha sık takip (3-6 ay). Spinal lezyonlarda nörolojik muayene takibi.Osteoblastoma diagnosis is made by combination of CT + MRI + biopsy. Distinguishing aggressive osteoblastoma from osteosarcoma can be difficult even histopathologically — multidisciplinary tumor board evaluation is recommended. Scoliosis may develop in spinal osteoblastoma (pain-induced leaning toward convex side). Spinal stability must be preserved during surgery and instrumentation may be needed. Local recurrence rate after incomplete excision ranges from 10-20% (conventional) to 40-50% (aggressive).
Osteoblastoma is a benign tumor but a locally aggressive variant (aggressive osteoblastoma) exists. Treatment includes curettage or surgical resection. Surgery is more urgent in spinal lesions due to neurological compression risk. Recurrence rate is 10-20%. Aggressive osteoblastoma may transform to low-grade osteosarcoma (controversial).